(22), DPYSL2 upregulation correlated with tumor high-staging and poor prognosis in patients with BC, and promoted the malignant behavior of BC through enhancing aerobic glycolysis and EMT in vitro and in vivo experiments. The gene discussed is DPYSL2; the disease is breast cancer.